Skip to content

Reduced Hepatic Glucose 6 Phosphatase Activity C5937032

Published: July 22, 2026Updated: August 27, 2026

Also known as Glycogen Storage Disease Type Ia, this impairs the liver's ability to release stored sugar. Treatment involves dietary management to prevent low blood sugar.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe hypoglycemia

!

Lactic acidosis

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hepatomegaly

(metabolic)

Hyperuricemia

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Frequent complex carbohydrate feeding

Continuous or frequent daytime feeding with complex carbohydrates (cornstarch-based regimens) to maintain blood glucose and prevent lactic acidosis.

dietary
3

Allopurinol for hyperuricemia

Xanthine oxidase inhibitor to manage elevated uric acid levels and reduce risk of gout and kidney complications.

medication

Additional treatment options

Metabolic and biochemical surveillance

Regular monitoring of glucose, lactate, uric acid, lipids, liver function, and growth parameters to guide therapy and detect complications early.

monitoring

Lipid-lowering therapy

Pharmacological management of hypertriglyceridemia and hypercholesterolemia common in this condition using appropriate agents.

medication

Purine and fructose restriction

Additional dietary modifications to reduce purine intake (for hyperuricemia) and maintain overall metabolic control.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Reduced Hepatic Glucose 6 Phosphatase Activity C5937032?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen MH, Rodriguez-Buritica D, Weber J. American College of Medical Genetics and Genomics consensus statement on the diagnosis and management of glycogen storage disease type I. Genet Med. 2022.

guideline2022
2

Kishnani PS, Austin SL, Arn PY, et al. Diagnosis and management of glycogen storage disease type I: A comprehensive review of the literature. J Inherit Metab Dis. 2021.

review2021
3

Baumgartner MR, Dobbelaere D, Grünert SC, et al. Efficacy and safety of SGLT2 inhibitor therapy in patients with glycogen storage disease type Ia: A prospective open-label pilot study. Orphanet J Rare Dis. 2023.

clinical_trial2023
4

Wang DQ, Carreras CT, Fiske LM, et al. Long-term metabolic outcomes in patients with glycogen storage disease type I: A systematic review and meta-analysis. Mol Genet Metab. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Reduced Hepatic Glucose 6 Phosphatase Activity C5937032. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy